Maines M D
J Exp Med. 1976 Dec 1;144(6):1509-19. doi: 10.1084/jem.144.6.1509.
Polychlorinated biphenyls (PCB) are potent inducers of hepatic microsomal CO-binding hemoprotein P-448 (P1-450) and of delta-aminolevulinate synthetase (ALAS) activity. Inorganic cobalt was able to block PCB induction of cytochrome P-448 and to modify the PCB effect on ALAS activity in a time-dependent manner. PCB were also found to decrease the activity of delta-aminolevulinic acid dehydratase (ALAD) in liver. Pretreatment of rats with cobalt (30 min) produced the following changes in PCB actions on heme metabolism in liver: (a) augmentation of the porphyrinogenic effect of PCB, as determined by the total porphyrin content and ALAS activity; (b) augmentation of PCB inhibition of ALAD activity; and (c) blockade of induction of microsomal hemoprotein (cytochrome P-448). PCB did not interfere with cobalt induction of hepatic heme oxygenase activity. The sequence of administration of the metal and the PCB was important in relation to the changes produced in hepatic ALAS activity and microsomal hemoprotein and heme contents. When cobalt was administered 24 h after PCB treatment, the magnitude of induction of ALAS by PCB was lowered, and there was a great reduction in microsomal hemoprotein and heme contents. The renal response to PCB was different than that of the liver. In the kidney, PCB blocked the induction of heme oxygenase and depletion of cellular heme produced by cobalt. Furthermore, renal microsomal heme content was increased by PCB treatment alone or in combination with cobalt. It is concluded that (a) the heme moiety of microsomal cytochrome P-448 is metabolized by the heme oxygenase system, and it is suggested that for this catabolism to take place, the hemoprotein must be first converted to the denatured form of the hemoprotein, cytochrome P-420; (b) that the synthesis of heme in the kidney and the liver are regulated through different mechanisms; and (c) that ionic cobalt controls activity of ALAS by first inhibiting synthesis of the enzyme followed by the indirect induction of the enzyme as a result of the catabolism of heme, the physiological repressor of ALAS, by the metal-induced heme oxygenase. Thus microsomal heme oxygenase may be viewed as having an overall regulatory role in relation to mictochondrial ALAS by virtue of its ability to catabolize endogenous heme.
多氯联苯(PCB)是肝微粒体一氧化碳结合血红蛋白P - 448(P1 - 450)和δ-氨基乙酰丙酸合成酶(ALAS)活性的强效诱导剂。无机钴能够阻断PCB对细胞色素P - 448的诱导作用,并以时间依赖的方式改变PCB对ALAS活性的影响。还发现PCB会降低肝脏中δ-氨基乙酰丙酸脱水酶(ALAD)的活性。用钴预处理大鼠(30分钟)会使PCB对肝脏血红素代谢的作用产生以下变化:(a)通过总卟啉含量和ALAS活性确定,增强PCB的致卟啉生成作用;(b)增强PCB对ALAD活性的抑制作用;(c)阻断微粒体血红蛋白(细胞色素P - 448)的诱导。PCB不干扰钴对肝脏血红素加氧酶活性的诱导。金属和PCB的给药顺序对于肝脏ALAS活性、微粒体血红蛋白和血红素含量产生的变化很重要。当在PCB处理后24小时给予钴时,PCB对ALAS的诱导程度降低,微粒体血红蛋白和血红素含量大幅减少。肾脏对PCB的反应与肝脏不同。在肾脏中,PCB阻断了钴诱导的血红素加氧酶和细胞血红素的消耗。此外,单独或与钴联合使用PCB处理均可增加肾脏微粒体血红素含量。得出以下结论:(a)微粒体细胞色素P - 448的血红素部分由血红素加氧酶系统代谢,并且表明为了发生这种分解代谢,血红蛋白必须首先转化为血红蛋白的变性形式,即细胞色素P - 420;(b)肾脏和肝脏中血红素的合成通过不同机制调节;(c)离子钴通过首先抑制该酶的合成来控制ALAS的活性,随后由于金属诱导的血红素加氧酶对ALAS的生理抑制剂血红素的分解代谢而间接诱导该酶。因此,微粒体血红素加氧酶由于其分解内源性血红素的能力,可能被视为对线粒体ALAS具有整体调节作用。